CMS In Brief
This article was originally published in The Gray Sheet
Executive Summary
Medicare advisors to meet on ventricular assist devices. CMS decides on coverage-with-evidence development for platelet-rich plasma wound care gel. More news from the Medicare agency.
You may also be interested in...
Clinical Lab And DME Payments Face Cuts Under Obama Budget
The 2014 federal budget request submitted by President Obama April 10 includes proposals to cut clinical lab services and to limit Medicaid reimbursement for durable medical equipment, among other cuts that would affect the medtech industry.
Invacare Compliance Challenges, Product Delays Impact Q3 Results
Talks with FDA are ongoing about compliance with quality system regulations and a proposed consent decree that would shut down certain operations at a wheelchair manufacturing plant in Elyria, Ohio, executives said during the firm’s Oct. 25 earnings call.
Wound Therapy Firm Pushes For More Flexibility In Coverage-With-Evidence Conditions
CMS recently proposed to lift a long-established non-coverage policy for platelet-rich plasma wound therapy, but only for patients enrolled in a randomized trial. Manufacturer Cytomedix says a registry-based observational study would be a better approach.